The DOI matches its Crossref record; 124 of the 124 references it cites were found in a registry or an index.
Essential Hypertension, Progressive Renal Disease, and Uric Acid: A Pathogenetic Link?
Abstract
Hypertension and hypertension-associated ESRD are epidemic in society. The mechanisms responsible for renal progression in mild to moderate hypertension and those groups most at risk need to be identified. Historic, epidemiologic, clinical, and experimental studies on the pathogenesis of hypertension and hypertension-associated renal disease are reviewed and an overview/hypothesis for the mechanisms involved in renal progression is presented. There is increasing evidence that hypertension may exist in one of two forms/stages. The first stage, most commonly observed in early or borderline hypertension, is characterized by salt-resistance, normal or only slightly decreased GFR, relatively normal or mild renal arteriolosclerosis, and normal renal autoregulation. This group is at minimal risk for renal progression. The second stage, characterized by salt-sensitivity, renal arteriolar disease, and blunted renal autoregulation, defines a group at highest risk for the development of microalbuminuria, albuminuria, and progressive renal disease. This second stage is more likely to be observed in blacks, in subjects with gout or hyperuricemia, with low level lead intoxication, or with severe obesity/metabolic syndrome. The two major mechanistic pathways for causing impaired autoregulation at mild to moderate elevations in BP appear to be hyperuricemia and/or low nephron number. Understanding the pathogenetic pathways mediating renal progression in hypertensive subjects should help identify those subjects at highest risk and may provide insights into new therapeutic maneuvers to slow or prevent progression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group (2002) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.288.23.2981 · Cited by 5,664
Blood pressure, stroke, and coronary heart disease
Collins, R., Peto, R., MacMahon, S., Godwin, J., Qizilbash, N., Collins, R., MacMahon, S., Hebert, P., Eberlein, K. A., Taylor, J. O., et al. (1990) · The Lancet · doi:10.1016/0140-6736(90)90944-z · Cited by 4,491
Blood Pressure and End-Stage Renal Disease in Men
Klag, M. J., Whelton, P. K., Randall, B. L., Neaton, J. D., Brancati, F. L., Ford, C. E., Shulman, N. B., & Stamler, J. (1996) · New England Journal of Medicine · doi:10.1056/nejm199601043340103 · Cited by 1,663
Is There a Pathogenetic Role for Uric Acid in Hypertension and Cardiovascular and Renal Disease?
Johnson, R. J., Kang, D.-H., Feig, D., Kivlighn, S., Kanellis, J., Watanabe, S., Tuttle, K. R., Rodriguez-Iturbe, B., Herrera-Acosta, J., & Mazzali, M. (2003) · Hypertension · doi:10.1161/01.hyp.0000069700.62727.c5 · Cited by 1,361
Self-citationElevated Uric Acid Increases Blood Pressure in the Rat by a Novel Crystal-Independent Mechanism
Mazzali, M., Hughes, J., Kim, Y.-G., Jefferson, J. A., Kang, D.-H., Gordon, K. L., Lan, H. Y., Kivlighn, S., & Johnson, R. J. (2001) · Hypertension · doi:10.1161/hy1101.092839 · Cited by 1,300
Self-citationObesity-related glomerulopathy: An emerging epidemic
Kambham, N., Markowitz, G. S., Valeri, A. M., Lin, J., & D'Agati, V. D. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.0590041498.x · Cited by 1,286
Brown, M. J., Palmer, C. R., Castaigne, A., de Leeuw, P. W., Mancia, G., Rosenthal, T., & Ruilope, L. M. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02527-7 · Cited by 1,209
Guyton, A. C., Coleman, T. G., Cowley, A. W., Scheel, K. W., Manning, R. D., & Norman, R. A. (1972) · The American Journal of Medicine · doi:10.1016/0002-9343(72)90050-2 · Cited by 1,050
Agodoa, L. Y. (2001) · JAMA · doi:10.1001/jama.285.21.2719 · Cited by 944
The Burden of Adult Hypertension in the United States 1999 to 2000: A Rising Tide
Fields, L. E., Burt, V. L., Cutler, J. A., Hughes, J., Roccella, E. J., & Sorlie, P. (2004) · Hypertension · doi:10.1161/01.hyp.0000142248.54761.56 · Cited by 906
Facchini, F. (1991) · JAMA · doi:10.1001/jama.1991.03470210076036 · Cited by 885
The Kidney, Hypertension, and Obesity
Hall, J. E. (2003) · Hypertension · doi:10.1161/01.hyp.0000052314.95497.78 · Cited by 868
Mazzali, M., Kanellis, J., Han, L., Feng, L., Xia, Y.-Y., Chen, Q., Kang, D.-H., Gordon, K. L., Watanabe, S., Nakagawa, T., et al. (2002) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00283.2001 · Cited by 826
Self-citationSOME DIFFERENT TYPES OF ESSENTIAL HYPERTENSION: THEIR COURSE AND PROGNOSIS
KEITH, N. M., WAGENER, H. P., & BARKER, N. W. (1974) · The American Journal of the Medical Sciences · doi:10.1097/00000441-197412000-00004 · Cited by 821
初期食道静脈りゅう治療におけるテルイプレシン(グリプレシン)とバソプレシンの比較試験
Freeman, J. G., Cobden, I., Lishman, A. H., & Record, C. O. (1982) · The Lancet · Cited by 773
Randomised trial of treatment of hypertension in elderly patients in primary care.
Coope, J., & Warrender, T. S. (1986) · BMJ · doi:10.1136/bmj.293.6555.1145 · Cited by 725
The vascular NAD(P)H oxidases as therapeutic targets in cardiovascular diseases
Cai, H., Griendling, K. K., & Harrison, D. G. (2003) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(03)00233-5 · Cited by 687
The Effect of Weight Loss on the Sensitivity of Blood Pressure to Sodium in Obese Adolescents
Rocchini, A. P., Key, J., Bondie, D., Chico, R., Moorehead, C., Katch, V., & Martin, M. (1989) · New England Journal of Medicine · doi:10.1056/nejm198908313210905 · Cited by 621
End-stage renal disease in African-American and white men. 16-year MRFIT findings
Klag, M. J. (1997) · JAMA · doi:10.1001/jama.277.16.1293 · Cited by 612
Coresh, J., Wei, G. L., McQuillan, G., Brancati, F. L., Levey, A. S., Jones, C., & Klag, M. J. (2001) · Archives of Internal Medicine · doi:10.1001/archinte.161.9.1207 · Cited by 587
Uric Acid, Hominoid Evolution, and the Pathogenesis of Salt-Sensitivity
Watanabe, S., Kang, D.-H., Feng, L., Nakagawa, T., Kanellis, J., Lan, H., Mazzali, M., & Johnson, R. J. (2002) · Hypertension · doi:10.1161/01.hyp.0000028589.66335.aa · Cited by 563
Self-citationSanchez-Lozada, L. G., Tapia, E., Santamaria, J., Avila-Casado, C., Soto, V., Nepomuceno, T., Rodriguez-Iturbe, B., Johnson, R. J., & Herrera-Acosta, J. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.00074.x · Cited by 556
Self-citationHaroun, M. K., Jaar, B. G., Hoffman, S. C., Comstock, G. W., Klag, M. J., & Coresh, J. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000095249.99803.85 · Cited by 532
The impact of serum uric acid on cardiovascular outcomes in the LIFE study
Høieggen, A., Alderman, M. H., Kjeldsen, S. E., Julius, S., Devereux, R. B., de Faire, U., Fyhrquist, F., Ibsen, H., Kristianson, K., Lederballe-Pedersen, O., et al. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00484.x · Cited by 473
Subtle Acquired Renal Injury as a Mechanism of Salt-Sensitive Hypertension
Johnson, R. J., Herrera-Acosta, J., Schreiner, G. F., & Rodríguez-Iturbe, B. (2002) · New England Journal of Medicine · doi:10.1056/nejmra011078 · Cited by 448
Self-citationPathophysiology of Hypertensive Renal Damage: Implications for Therapy
Bidani, A. K., & Griffin, K. A. (2004) · Hypertension · doi:10.1161/01.hyp.0000145180.38707.84 · Cited by 422
ISEKI, K., OSHIRO, S., TOZAWA, M., ISEKI, C., IKEMIYA, Y., & TAKISHITA, S. (2001) · Hypertension Research · doi:10.1291/hypres.24.691 · Cited by 386
Sodium and volume sensitivity of blood pressure. Age and pressure change over time.
Weinberger, M. H., & Fineberg, N. S. (1991) · Hypertension · doi:10.1161/01.hyp.18.1.67 · Cited by 382
Association between blood pressure and the rate of decline in renal function with age
Lindeman, R. D., Tobin, J. D., & Shock, N. W. (1984) · Kidney International · doi:10.1038/ki.1984.229 · Cited by 364
Early Predictors of 15-Year End-Stage Renal Disease in Hypertensive Patients
Perry, H. M., Miller, J. P., Fornoff, J. R., Baty, J. D., Sambhi, M. P., Rutan, G., Moskowitz, D. W., & Carmody, S. E. (1995) · Hypertension · doi:10.1161/01.hyp.25.4.587 · Cited by 347
Bigazzi, R., Bianchi, S., Baldari, D., & Campese, V. M. (1998) · Journal of Hypertension · doi:10.1097/00004872-199816090-00014 · Cited by 331
Franse, L. V., Pahor, M., Bari, M. D., Shorr, R. I., Wan, J. Y., Somes, G. W., & Applegate, W. B. (2000) · Journal of Hypertension · doi:10.1097/00004872-200018080-00021 · Cited by 307
Mild hyperuricemia induces glomerular hypertension in normal rats
Sánchez-Lozada, L. G., Tapia, E., Avila-Casado, C., Soto, V., Franco, M., Santamaría, J., Nakagawa, T., Rodríguez-Iturbe, B., Johnson, R. J., & Herrera-Acosta, J. (2002) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00170.2002 · Cited by 297
Self-citationArteriolar Sclerosis in Hypertensive and Non-Hypertensive Individuals.
Moritz, A. R., & Oldt, M. R. (1937) · PubMed · Cited by 296
Savage, P. J. (1998) · Archives of Internal Medicine · doi:10.1001/archinte.158.7.741 · Cited by 292
Environmental Lead Exposure and Progression of Chronic Renal Diseases in Patients without Diabetes
Lin, J.-L., Lin-Tan, D.-T., Hsu, K.-H., & Yu, C.-C. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021672 · Cited by 288
Wg, W. (1992) · JAMA · doi:10.1001/jama.268.21.3085 · Cited by 285
Rodríguez-Iturbe, B., Vaziri, N. D., Herrera-Acosta, J., & Johnson, R. J. (2004) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00269.2003 · Cited by 277
Self-citationHyperuricemia Causes Glomerular Hypertrophy in the Rat
Nakagawa, T., Mazzali, M., Kang, D.-H., Kanellis, J., Watanabe, S., Sanchez-Lozada, L. G., Rodriguez-Iturbe, B., Herrera-Acosta, J., & Johnson, R. J. (2003) · American Journal of Nephrology · doi:10.1159/000066303 · Cited by 269
Self-citationRelation between dose of bendrofluazide, antihypertensive effect, and adverse biochemical effects.
Carlsen, J. E., Køber, L., Torp-Pedersen, C., & Johansen, P. (1990) · BMJ · doi:10.1136/bmj.300.6730.975 · Cited by 269
Johnson, R. J., Kivlighn, S. D., Kim, Y.-G., Suga, S., & Fogo, A. B. (1999) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(99)70295-7 · Cited by 267
Self-citationHypertensive vascular disease; description and natural history
Perera, G. A. (1955) · Journal of Chronic Diseases · doi:10.1016/0021-9681(55)90019-9 · Cited by 264
UTERINE PULSATION AS SIGN OF EARLY PREGNANCY
Sargentis, V. (1974) · The Lancet · doi:10.1016/s0140-6736(74)91237-9 · Cited by 257
Hypertriglyceridaemia and hyperuricaemia are risk factors for progression of IgA nephropathy
Syrjänen, J., Mustonen, J., & Pasternack, A. (2000) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/15.1.34 · Cited by 257
Obesity-Initiated Metabolic Syndrome and the Kidney: A Recipe for Chronic Kidney Disease?
Bagby, S. P. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000141965.28037.ee · Cited by 257
Pathogenesis of cyclosporine nephropathy: roles of angiotensin II and osteopontin.
Pichler, R. H., Franceschini, N., Young, B. A., Hugo, C., Andoh, T. F., Burdmann, E. A., Shankland, S. J., Alpers, C. E., Bennett, W. M., & Couser, W. G. (1995) · Journal of the American Society of Nephrology · doi:10.1681/asn.v641186 · Cited by 256
TALBOTT, J. H., & TERPLAN, K. L. (1960) · Medicine · doi:10.1097/00005792-196012000-00001 · Cited by 252
EVALUATION OF RENAL RESISTANCES, WITH SPECIAL REFERENCE TO CHANGES IN ESSENTIAL HYPERTENSION 1
Gómez, D. M. (1951) · Journal of Clinical Investigation · doi:10.1172/jci102534 · Cited by 252
Renal Insufficiency in Treated Essential Hypertension
Rostand, S. G., Brown, G., Kirk, K. A., Rutsky, E. A., & Dustan, H. P. (1989) · New England Journal of Medicine · doi:10.1056/nejm198903163201102 · Cited by 249
Fogo, A., Breyer, J. A., Smith, M. C., Cleveland, W. H., Agodoa, L., Kirk, K. A., Glassock, R., & The AASK Pilot Study Investigators (1997) · Kidney International · doi:10.1038/ki.1997.29 · Cited by 247
Microalbuminuria in salt-sensitive patients. A marker for renal and cardiovascular risk factors.
Bigazzi, R., Bianchi, S., Baldari, D., Sgherri, G., Baldari, G., & Campese, V. M. (1994) · Hypertension · doi:10.1161/01.hyp.23.2.195 · Cited by 246
Muntner, P., He, J., Vupputuri, S., Coresh, J., & Batuman, V. (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00812.x · Cited by 240
Uric acid, evolution and primitive cultures
Johnson, R. J., Titte, S., Cade, J. R., Rideout, B. A., & Oliver, W. J. (2005) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2004.09.002 · Cited by 225
Self-citationDoes hyperuricemia aeffect mortality? A prospective cohort study of Japanese male workers.
Tomita, M., Mizuno, S., Yamanaka, H., Hosoda, Y., Sakuma, K., Matuoka, Y., Odaka, M., Yamaguchi, M., Yosida, H., Morisawa, H., et al. (2000) · Journal of Epidemiology · doi:10.2188/jea.10.403 · Cited by 225
Uric acid and the state of the intrarenal renin-angiotensin system in humans
Perlstein, T. S., Gumieniak, O., Hopkins, P. N., Murphey, L. J., Brown, N. J., Williams, G. H., Hollenberg, N. K., & Fisher, N. D. L. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00909.x · Cited by 214
RANGE OF NORMAL BLOOD PRESSURE: A STATISTICAL AND CLINICAL STUDY OF 11,383 PERSONS
ROBINSON, S. C. (1939) · Archives of Internal Medicine · doi:10.1001/archinte.1939.00190030002001 · Cited by 211
Abnormal renal hemodynamics in black salt-sensitive patients with hypertension.
Campese, V. M., Parise, M., Karubian, F., & Bigazzi, R. (1991) · Hypertension · doi:10.1161/01.hyp.18.6.805 · Cited by 196
A CLINICAL STUDY OF HYPERTENSIVE CARDIOVASCULAR DISEASE
JANEWAY, T. C. (1913) · Archives of Internal Medicine · doi:10.1001/archinte.1913.00070060147012 · Cited by 189
Renal autoregulation: perspectives from whole kidney and single nephron studies
Navar, L. G. (1978) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1978.234.5.f357 · Cited by 185
Histologic studies of kidney biopsy specimens from patients with hypertension.
Sommers, S. C., Relman, A. S., & Smithwick, R. H. (1958) · PubMed · Cited by 184
Renal and nephron hemodynamics in spontaneously hypertensive rats
Arendshorst, W. J., & Beierwaltes, W. H. (1979) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1979.236.3.f246 · Cited by 171
Serum Uric Acid and Renal Prognosis in Patients with IgA Nephropathy
Ohno, I., Hosoya, T., Gomi, H., Ichida, K., Okabe, H., & Hikita, M. (2001) · Nephron · doi:10.1159/000045939 · Cited by 169
Quiroz, Y., Pons, H., Gordon, K. L., Rincón, J., Chávez, M., Parra, G., Herrera-Acosta, J., Gómez-Garre, D., Largo, R., Egido, J., et al. (2001) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.2001.281.1.f38 · Cited by 167
Self-citationVerani, R. R. (1992) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(12)70230-5 · Cited by 164
Cloning and Characterization of Two New Isoforms of the Rat Kidney Urea Transporter: UT-A3 and UT-A4
KARAKASHIAN, A., TIMMER, R. T., KLEIN, J. D., GUNN, R. B., SANDS, J. M., & BAGNASCO, S. M. (1999) · Journal of the American Society of Nephrology · doi:10.1681/asn.v102230 · Cited by 162
Insulin Resistance, Elevated Glomerular Filtration Fraction, and Renal Injury
Dengel, D. R., Goldberg, A. P., Mayuga, R. S., Kairis, G. M., & Weir, M. R. (1996) · Hypertension · doi:10.1161/01.hyp.28.1.127 · Cited by 161
Sealey, J. E., Blumenfeld, J. D., Bell, G. M., Pecker, M. S., Sommers, S. C., & Laragh, J. H. (1988) · Journal of Hypertension · doi:10.1097/00004872-198811000-00001 · Cited by 161
Angiotensin-induced defects in renal oxygenation: role of oxidative stress
Welch, W. J., Blau, J., Xie, H., Chabrashvili, T., & Wilcox, C. S. (2004) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00626.2004 · Cited by 161
Salt-Sensitive Hypertension Develops After Short-Term Exposure to Angiotensin II
Lombardi, D. M., GORDON, K. L., Polinsky, P., Suga, S., Schwartz, S. M., & Johnson, R. J. (1999) · Hypertension · doi:10.1161/01.hyp.33.4.1013 · Cited by 155
Self-citationRenal outcomes of gout and hyperuricemia
(1979) · The American Journal of Medicine · doi:10.1016/0002-9343(79)90084-6 · Cited by 139
Metoprolol versus thiazide diuretics in hypertension. Morbidity results from the MAPHY Study.
Wikstrand, J., Warnold, I., Tuomilehto, J., Olsson, G., Barber, H. J., Eliasson, K., Elmfeldt, D., Jastrup, B., KARATZAS, N. B., & Leer, J. (1991) · Hypertension · doi:10.1161/01.hyp.17.4.579 · Cited by 136
Racial differences in the incidence of gout
Hochberg, M. C., Thomas, J. W., Thomas, D., Mead, L. A., Levine, D., & Klag, M. J. (1995) · Arthritis & Rheumatism · doi:10.1002/art.1780380508 · Cited by 131
A Prospective Study of Blood Pressure and Serum Creatinine
Perneger, T. V. (1993) · JAMA · doi:10.1001/jama.1993.03500040054036 · Cited by 129
Microalbuminuria, renal dysfunction and cardiovascular complication in essential hypertension
Cerasola, G., Cottone, S., Mulè, G., et al. (1996) · Journal of Hypertension · doi:10.1097/00004872-199607000-00016 · Cited by 128
Yu, C., Lin, J., & Lin‐Tan, D. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000118529.01681.4f · Cited by 123
Hill, G. S., Heudes, D., & Bariety, J. (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00831.x · Cited by 122
Voyaki, S. M., Staessen, J. A., Thijs, L., Wang, J. G., Efstratopoulos, A. D., Birkenhäger, W. H., de Leeuw, P. W., Leonetti, G., Nachev, C., Rodicio, J. L., et al. (2001) · Journal of Hypertension · doi:10.1097/00004872-200103000-00020 · Cited by 120
Rosansky, S. J. (1990) · Archives of Internal Medicine · doi:10.1001/archinte.1990.00390210059014 · Cited by 118
Hypokalemia induces renal injury and alterations in vasoactive mediators that favor salt sensitivity
Suga, S., Phillips, M. I., Ray, P. E., Raleigh, J. A., Vio, C. P., Kim, Y.-G., Mazzali, M., GORDON, K. L., Hughes, J., & Johnson, R. J. (2001) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.2001.281.4.f620 · Cited by 112
Self-citationDahlöf, B., Stenkula, S., & Hansson, L. (1992) · Blood Pressure · doi:10.3109/08037059209065122 · Cited by 104
Renal Injury and Salt-Sensitive Hypertension After Exposure to Catecholamines
Johnson, R. J., GORDON, K. L., Suga, S., Duijvestijn, A. M., Griffin, K. A., & BIDANI, A. K. (1999) · Hypertension · doi:10.1161/01.hyp.34.1.151 · Cited by 103
Self-citationClinical Significance of Renal Function in Hypertensive Patients at High Risk
de Leeuw, P. W., Ruilope, L. M., Palmer, C. R., Brown, M. J., Castaigne, A., Mancia, G., Rosenthal, T., & Wagener, G. (2004) · Archives of Internal Medicine · doi:10.1001/archinte.164.22.2459 · Cited by 101
Progressive renal disease: Role of race and antihypertensive medications
Brazy, P. C., & Fitzwilliam, J. F. (1990) · Kidney International · doi:10.1038/ki.1990.93 · Cited by 94
Franco, M., Tapia, E., Santamaría, J., ZAFRA, I., García-Torres, R., GORDON, K. L., Pons, H., Rodríguez‐Iturbe, B., Johnson, R. J., & Herrera-Acosta, J. (2001) · Journal of the American Society of Nephrology · doi:10.1681/asn.v12112263 · Cited by 93
Self-citationAge, race, diagnosis, and sodium effects on the pressor response to infused norepinephrine.
Dimsdale, J. E., Graham, R. M., Ziegler, M. G., Zusman, R. M., & Berry, C. C. (1987) · Hypertension · doi:10.1161/01.hyp.10.6.564 · Cited by 87
Effects of Black Race on Forearm Resistance Vessel Function
Kahn, D. F., Duffy, S. J., Tomasian, D., HOLBROOK, M. M., Rescorl, L., Russell, J. D., Gokce, N., Loscalzo, J., & Vita, J. A. (2002) · Hypertension · doi:10.1161/01.hyp.0000024571.69634.ed · Cited by 87
Births and deaths: preliminary data for 1998.
Martin, J. A., Smith, B. L., Mathews, T. J., & Ventura, S. J. (1999) · PubMed · Cited by 87
Transforming growth factor-β1 hyperexpression in African American end-stage renal disease patients
Suthanthiran, M., Khanna, A. K., Cukran, D., Adhikarla, R., Sharma, V. K., Singh, T., & August, P. (1998) · Kidney International · doi:10.1046/j.1523-1755.1998.00858.x · Cited by 86
Benign and Malignant Hypertension and Nephrosclerosis: A Clinical and Pathological Study.
Kimmelstiel, P., & Wilson, C. (1936) · PubMed Central · Cited by 84
Inhibitors of 20-HETE Formation Promote Salt-Sensitive Hypertension in Rats
Hoagland, K. M., Flasch, A. K., & Roman, R. J. (2003) · Hypertension · doi:10.1161/01.hyp.0000084634.97353.1a · Cited by 84
Renal Proliferative and Phenotypic Changes in Rats With Two-Kidney, One-Clip Goldblatt Hypertension
Eng, E., Véniant, M. M., Floege, J., Fingerle, J., Alpers, C. E., Ménard, J., Clozel, J., & Johnson, R. J. (1994) · American Journal of Hypertension · doi:10.1093/ajh/7.2.177 · Cited by 84
Self-citationShadick, N. A., Kim, Y., Weiss, S. T., Liang, M. H., Sparrow, D., & Hu, H. (2000) · PubMed · Cited by 82
The Etiology of Bright's Disease and the Prealbuminuric Stage
Mahomed, F. A. (1874) · Journal of the Royal Society of Medicine · doi:10.1177/095952877405700118 · Cited by 82
Role of 20-hydroxyeicosatetraenoic acid and epoxyeicosatrienoic acids in hypertension
Sarkis, A., López, B., & Roman, R. J. (2004) · Current Opinion in Nephrology & Hypertension · doi:10.1097/00041552-200403000-00009 · Cited by 78
Projections of Hypertension-Related Renal Disease in Middle-aged Residents of the United States
Perneger, T. (1993) · JAMA · doi:10.1001/jama.1993.03500100070030 · Cited by 78
Changes in renal function in essential hypertension
Reubi, F. C., Weidmann, P. U., Hodler, J., & COTTIER, P. T. (1978) · The American Journal of Medicine · doi:10.1016/0002-9343(78)90573-9 · Cited by 78
Microvascular and tubulointerstitial injury associated with chronic hypoxia-induced hypertension
Mazzali, M., Jefferson, J. A., Ni, Z., Vaziri, N. D., & Johnson, R. J. (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00011.x · Cited by 77
Self-citationRisks and benefits in the trial of the European Working Party on High Blood Pressure in the Elderly
FLETCHER, A. E., Amery, A. A., Birkenhäger, W. H., Bulpitt, C. J., Clement, D. L., de Leeuw, P. W., Deruyttere, M., Schaepdryver, A. D., Dollery, C. T., Fagard, R., et al. (1991) · Journal of Hypertension · doi:10.1097/00004872-199103000-00005 · Cited by 75
Births and deaths: preliminary data for 1997.
Sj, V., Rn, A., Ja, M., & Bl, S. (1998) · PubMed · Cited by 75
Hoenderop, J. G. J., Pont, J. J. H. H. M. D., Bindels, R. J. M., & Willems, P. H. G. M. (1999) · Kidney International · doi:10.1046/j.1523-1755.1999.00228.x · Cited by 73
Knox, S. S., Hausdorff, J. M., & Markovitz, J. H. (2002) · Hypertension · doi:10.1161/01.hyp.0000041417.94797.57 · Cited by 70
Tapia, E., Franco, M., Sánchez‐Lozada, L. G., Soto, V., Ávila-Casado, C., Santamaría, J., Quiroz, Y., Rodríguez‐Iturbe, B., & Herrera-Acosta, J. (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00811.x · Cited by 65
Self-citationPrognosis in Essential Hypertension
PALMER, R. S., Loofbourow, D. G., & Doering, C. R. (1948) · New England Journal of Medicine · doi:10.1056/nejm194812232392602 · Cited by 65
Impaired autoregulation of renal blood flow in the fawn-hooded rat
van Dokkum, R. P. E., Alonso‐Galicia, M., Provoost, A. P., Jacob, H. J., & Roman, R. J. (1999) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1999.276.1.r189 · Cited by 62
HYPERTENSIVE CARDIOVASCULAR DISEASE
Smithwick, R. H. (1951) · JAMA · doi:10.1001/jama.1951.03670340001001 · Cited by 61
Advances in our understanding of aging: role of the renin–angiotensin system
Ferder, L. (2002) · Current Opinion in Pharmacology · doi:10.1016/s1471-4892(02)00139-x · Cited by 61
Blood Pressure and Renal Function
Ljungman, S., Aurell, M., Hartford, M., et al. (1980) · Acta Medica Scandinavica · doi:10.1111/j.0954-6820.1980.tb01144.x · Cited by 60
Renal function during antihypertensive treatment
Madhavan, S., Stockwell, D. H., Cohen, H. W., & Alderman, M. H. (1995) · The Lancet · doi:10.1016/s0140-6736(95)90638-x · Cited by 58
Griffin, K. A., Picken, M. M., & BIDANI, A. K. (2003) · Kidney International · doi:10.1111/j.1523-1755.2004.00356.x · Cited by 57
de Leeuw, P. W. (1991) · The American Journal of Medicine · doi:10.1016/0002-9343(91)90436-2 · Cited by 51
Does non-malignant hypertension cause renal insufficiency? Evidence-based perspective
Hsu, C. (2002) · Current Opinion in Nephrology & Hypertension · doi:10.1097/00041552-200205000-00001 · Cited by 49
Andoh, T. F., Johnson, R. J., Lam, T., & Bennett, M. (2001) · American Journal of Transplantation · doi:10.1046/j.1600-6135.ajt10305.x · Cited by 42
Self-citationThe Metabolic Syndrome as a Risk Factor for Chronic Kidney Disease
Schelling, J. R., & Sedor, J. R. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000141964.68839.bb · Cited by 42
Hypertension in African Americans: the role of sodium chloride and extracellular fluid volume.
Weinberger, M. H. (1996) · PubMed · Cited by 38
Predictors of Target Organ Damage in Hypertensive Blacks and Whites
El‐Gharbawy, A., Kotchen, J. M., Grim, C. E., Kaldunski, M. L., Hoffmann, R. G., Pausová, Z., Gaudet, D., Gossard, F., Hamet, P., & Kotchen, T. A. (2001) · Hypertension · doi:10.1161/hy1001.092613 · Cited by 35
Renal sodium excretion and the peritubular capillary physical factors in essential hypertension.
Willassen, Y., & Ofstad, J. (1980) · Hypertension · doi:10.1161/01.hyp.2.6.771 · Cited by 33
The Renal Circulation in Essential Hypertension
de Leeuw, P. W., & ger, W. H. B. (1983) · Journal of Hypertension · doi:10.1097/00004872-198312000-00001 · Cited by 33
A Single Pathway for the Development of Essential Hypertension
Kanellis, J., Nakagawa, T., Herrera-Acosta, J., Schreiner, G. F., GUEZ-ITURBE, B. R., & Johnson, R. J. (2003) · Cardiology in Review · doi:10.1097/01.crd.0000077361.00668.14 · Cited by 30
Self-citationBirths and deaths: preliminary data for July 1997-June 1998.
Smith, B. L., Martin, J. A., & Ventura, S. J. (1999) · PubMed · Cited by 29
Hypertensive cardiovascular disease
Frohlich, E. D., Gifford, R. W., & Hall, W. D. (1987) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(87)80450-3 · Cited by 27
Progression of renal failure and hypertensive nephrosclerosis
Zucchelli, P. C., & Zuccalà, A. (1998) · Kidney International · doi:10.1046/j.1523-1755.1998.06814.x · Cited by 24
Treatment of glomerulonephritides associated with hepatitis C virus infection
Giannico, G. A., Manno, C., & Schena, F. P. (2000) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/15.suppl_8.34 · Cited by 10
Reams, G. P., & Bauer, J. H. (1990) · Cardiovascular Drugs and Therapy · doi:10.1007/bf01857635 · Cited by 8
Rahman, M. M., Nwachuku, C., Whelton, P. K., Probstfield, J. L., & DAVIS, B. (2006) · American Journal of Hypertension · doi:10.1016/j.amjhyper.2005.09.008 · Cited by 6
Cited by
De Rosa, S., Samoni, S., Villa, G., & Ronco, C. (2017) · Blood Purification · doi:10.1159/000452650 · Cited by 5,007
Special Issue: KDIGO Clinical Practice Guideline for the Care of Kidney Transplant Recipients
Eckardt, K.-U., Kasiske, B. L., & Zeier, M. G. (2009) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2009.02834.x · Cited by 1,499
Uric Acid: The Oxidant-Antioxidant Paradox
Sautin, Y. Y., & Johnson, R. J. (2008) · Nucleosides, Nucleotides and Nucleic Acids · doi:10.1080/15257770802138558 · Cited by 972
Self-citationFeig, D. I., Soletsky, B., & Johnson, R. J. (2008) · JAMA · doi:10.1001/jama.300.8.924 · Cited by 914
Self-citationUric acid transport and disease
So, A., & Thorens, B. (2010) · Journal of Clinical Investigation · doi:10.1172/jci42344 · Cited by 861
Metadata
- Authors
- Johnson, R. J., Segal, M. S., Srinivas, T., Ejaz, A., Mu, W., Roncal, C., Sánchez-Lozada, L. G., Gersch, M., Rodriguez-Iturbe, B., Kang, D.-H., & Acosta, J. H.
- Venue
- Journal of the American Society of Nephrology
- Published
- 2005-07
- Volume
- 16
- Issue
- 7
- Pages
- 1909-1919
- ISSN
- 1046-6673 (ISSN-L)
- OpenAlex
- W2117842210
- Cited by
- 280
- References
- 124
- FWCI
- 12.04
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.